International SAE Consortium (iSAEC)
United States of America (USA)
1 June 2019 - 31 May 2020
Research collaboration: International SAE Consortium (iSAEC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
International SAE Consortium (iSAEC)
Partner Institutions
International SAE Consortium (iSAEC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Abbott Laboratories, United States of America (USA)
- Amgen Inc., United States of America (USA)
- Cerner Corporation, United States of America (USA)
- Catholic Health Initiatives, United States of America (USA)
- Daiichi Sankyo Co., Ltd., Japan
- Johnson & Johnson, United States of America (USA)
- Merck & Co., Inc., United States of America (USA)
- Novartis International AG, Switzerland
- Roche Palo Alto, LLC, United States of America (USA)
- Sanofi-Aventis, United States of America (USA)
- Wellcome Trust, United Kingdom (UK)
- Wyeth, United States of America (USA)
- Broad Institute of MIT and Harvard, United States of America (USA)
- Columbia University in the City of New York (CU), United States of America (USA)
- Duke University, United States of America (USA)
- University of Dundee, United Kingdom (UK)
- Quintiles Inc., United States of America (USA)
- U.S. Food and Drug Administration (USFDA), United States of America (USA)
- Illumina, Inc., United States of America (USA)
- Histogenetics LLC, United States of America (USA)
- University of Málaga (UMA), Spain
- Newcastle University, United Kingdom (UK)
- University of California, San Diego (UC San Diego), United States of America (USA)
- U.S. Department of Veterans Affairs, United States of America (USA)
- Drug-Induced Liver Injury Network (DILIN), United States of America (USA)
- Takeda Pharmaceutical Company Limited, Japan
